DAP:ETR
Danaher Corp
€180.20
arrow_upward
+4.19%(+7.25) 1D
Set 15, 5:35:39 PM GMT+2 · EUR
search
Lahat ng simbolo
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa DAP...
Buksan
€178.00
Mataas
€180.20
Mababa
€173.90
Mkt. cap
147.18B
Avg. na dami
518.00
Dami
1.64K
Mataas nang 52-wk
€208.30
Mababa nang 52-wk
€138.20
Bilang ng mga empleyado
59K
Buksan
€178.00
Mataas
€180.20
Mababa
€173.90
Mkt. cap
147.18B
Avg. na dami
518.00
Dami
1.64K
Mataas nang 52-wk
€208.30
Mababa nang 52-wk
€138.20
Bilang ng mga empleyado
59K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
GuruFocus
·
1 oras ang nakalipas
Danaher Corp (DHR) Shares Surge 3.0% -- What GF Score of 80 Tells Investors
Investing.com
·
2 oras ang nakalipas
Danaher declares $0.40 quarterly dividend
TradingKey
·
3 oras ang nakalipas
Danaher Corp Stock (DHR) Closed Up by 3.01% on Sep 15: A Full Analysis
TipRanks
·
1 araw ang nakalipas
Danaher Stock Slips As Sector Jitters Mount
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
Tungkol sa Danaher Corp